Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
INDUSTRY
×
Neoplasms, Squamous Cell
×
Clear all
Filters
3
NCT01283906
2013-09-12
MuGard
Access Pharmaceuticals, Inc.
Phase 4
Completed
120 enrolled